Posts by Mark B. Leick, MD
-
Combination Strategy Potentiates CAR T-cell Therapy for Acute Myeloid Leukemia
Acute myeloid leukemia has been challenging to treat with CAR T-cell therapy. Still, Marcela V. Maus, MD, PhD, Mark B. Leick, MD, and colleagues demonstrated good preclinical results after developing a non-cleavable "hinge" for CD70-targeted T cells and pretreating with azacitidine.
Biography
Mark B. Leick, MD, is a hematologic oncologist at the Massachusetts General Hospital Cancer Center and an instructor in medicine at Harvard Medical School.
Mass General Brigham Cancer Institute
Mass General Brigham Cancer Institute unites leading experts and resources across our academic medical centers, making it one of the nation’s top providers of cancer care.